Piperazine

Piperazine

SCHEMBL2783137

C1CNCCN1.O=P(O)(O)O.O=P(O)(O)O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.50
MAPT P10636 1/20 0.50
PDE4A P27815 1/20 0.50
KDR P35968 1/20 0.50
CXCR4 P61073 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CA2 P00918 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 3/20 0.32
PMP22 Q01453 2/20 0.32
CYP3A4 P08684 2/20 0.32
RGS12 O14924 1/20 0.32
GABRR1 P24046 1/20 0.32
GABRR2 P28476 1/20 0.32
MAPK1 P28482 1/20 0.32
BLM P54132 1/20 0.32
GNAI1 P63096 1/20 0.32
GABRA1 P14867 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperazine SCHEMBL5053500 1.00 HIF1A (0.50) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL28128235 1.00 HIF1A (0.50) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL27815540 1.00 HIF1A (0.50) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL27826049 1.00 HIF1A (0.50) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL227947 1.00 HIF1A (0.50) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL23235242 1.00 HIF1A (0.50) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL1972873 0.96 HIF1A (0.46) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL15364207 0.96 HIF1A (0.46) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL15363813 0.96 HIF1A (0.46) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL28092756 0.96 HIF1A (0.46) HIF1AMAPTPDE4AKDRCXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 291 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122079930-A Preparation method of piperazine diphosphate metal salt flame retardant 2026-05-26 CN claimed
US-20250230286-A1 CHEMICALLY END-CAPPED POLYPIPERAZINE PYROPHOSPHATE-MODIFIED AMMONIUM POLYPHOSPHATE WITH HIGH TEMPERATURE RESISTANCE AND PRECIPITATION RESISTANCE, PREPARATION METHOD THEREFOR, AND APPARATUS AND APPLICATION THEREOF Chongqing Copolyforce New Materials Co.,Ltd. (CN) 2025-07-17 US claimed
CN-120192590-A Migration-resistant piperazine pyrophosphate flame retardant and synthesis method thereof 四川精事达科技有限公司 2025-06-24 CN claimed
CN-119874774-A N, P, B integrated flame retardant and synthetic method and application thereof 四川兴晶铧科技有限公司 2025-04-25 CN claimed
CN-115385869-B High-whiteness piperazine pyrophosphate and preparation method and application thereof 金发科技股份有限公司 2025-03-18 CN claimed
CN-119431947-A Flame-retardant reinforced polypropylene composite material containing flame-retardant modified glass fiber and preparation method thereof 重庆科聚孚新材料有限责任公司 2025-02-14 CN claimed
CN-116410473-B Polymeric flame retardant and preparation method and application thereof 清远市普塞呋磷化学有限公司 2025-01-17 CN claimed
CN-119241092-A Flame-retardant modified glass fiber, preparation method thereof and application of flame-retardant reinforced polyamide 重庆科聚孚新材料有限责任公司 2025-01-03 CN claimed
CN-119019693-A Piperazine phosphate-ammonium phosphate copolymerized flame retardant, and preparation method and application thereof 重庆科聚孚新材料有限责任公司 2024-11-26 CN claimed
CN-118996859-A Flame-retardant modified carbon fiber, preparation method thereof and application of flame-retardant reinforced polypropylene 重庆科聚孚新材料有限责任公司 2024-11-22 CN claimed
US-20130296467-A1 FLAME-RETARDANT POLYOLEFIN RESIN CONTAINING PIPERAZINE-BASED METAL SALT BLEND LOTTE CHEMICAL CORPORATION (KR) 2013-11-07 US claimed
EP-1674459-B1 HIGH-PURITY PIPERAZINE PYROPHOSPHATE AND METHOD FOR PRODUCING SAME ADEKA CORP (JP) 2012-11-14 EP claimed
CN-101955472-B Preparation method of cinepazide maleate YING WANG 2012-11-14 CN claimed
US-20120190779-A1 (POLY) PIPERAZINE PYROPHOSPHATE POWDER AND MANUFACTURING METHOD THEREFOR SAKAI CHEMICAL INDUSTRY CO., LTD. (JP) 2012-07-26 US claimed
EP-2468738-A1 (POLY) PIPERAZINE PYROPHOSPHATE POWDER AND MANUFACTURING METHOD THEREFOR SAKAI CHEMICAL INDUSTRY CO., LTD. (JP) 2012-06-27 EP claimed
CN-100436433-C High-purity piperazine pyrophosphate and method for producing same ASAHI DENKA CO LTD (JP) 2008-11-26 CN claimed
US-7449577-B2 High purity piperazine pyrophosphate and process of producing same ADEKA CORPORATION (JP) 2008-11-11 US claimed
CN-1845913-A High-purity piperazine pyrophosphate and method for producing same ASAHI DENKA CO LTD (JP) 2006-10-11 CN claimed
US-20060167256-A1 High purity piperazine pyrophosphate and process of producing same ADEKA CORPORATION (JP) 2006-07-27 US claimed
EP-1674459-A1 HIGH-PURITY PIPERAZINE PYROPHOSPHATE AND METHOD FOR PRODUCING SAME Asahi Denka Co., Ltd. (JP) 2006-06-28 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167256-A1 High purity piperazine pyrophosphate and process of producing same DCTPP1, DHPS, PPA1 HIF1A 1978/4885MAPT 2264/4885PDE4A 1538/4885
US-20120190779-A1 (POLY) PIPERAZINE PYROPHOSPHATE POWDER AND MANUFACTURING METHOD THEREFOR PPIP5K2, GGPS1, ITPA HIF1A 1620/4885MAPT 2143/4885PDE4A 2683/4885
US-20250230286-A1 CHEMICALLY END-CAPPED POLYPIPERAZINE PYROPHOSPHATE-MODIFIED AMMONIUM POLYPHOSPHATE WITH HIGH TEMPERATURE RESISTANCE AND PRECIPITATION RESISTANCE, PREPARATION METHOD THEREFOR, AND APPARATUS AND APPLICATION THEREOF PPA1, DCTPP1, AGPS HIF1A 3959/4885MAPT 1847/4885PDE4A 4003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.